Stay updated with breaking news from Cibus Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cibus, Inc. (NASDAQ:CBUS – Get Free Report) saw a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 610,400 shares, a growth of 31.8% from the April 30th total of 463,000 shares. Currently, 4.3% of the company’s shares are sold short. Based on an average […]
Cibus, Inc. (NASDAQ:CBUS – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 610,400 shares, an increase of 31.8% from the April 30th total of 463,000 shares. Based on an average daily trading volume, of 68,800 shares, […]
• Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting • Execution of strategic...
SAN DIEGO, April 25, 2024 -- Cibus, Inc. , a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits in seeds, today announced that the...
HC Wainwright restated their buy rating on shares of Cibus (NASDAQ:CBUS – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $25.00 target price on the stock. Cibus Stock Up 5.3 % Shares of NASDAQ:CBUS opened at $21.45 on Friday. The company has a 50 day moving average of $18.13 […]